Skip to main content
SpringerLink
Log in

New treatments for breast cancer

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

In the course of developing new drugs to treat cancer, researchers have developed less toxic formulations of currently used active compounds. At the 18th San Antonio Breast Cancer Symposium [ San Antonio, Texas, US; December 1995 ], the results of phase I and II trials of liposome-encapsulated formulations of doxorubicin and daunorubicin were presented. Currently, the new formulations appear to be better tolerated, but less effective, than standard preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Robert H. Carlson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlson, R.H. New treatments for breast cancer. Inpharma Wkly. 1020, 8–9 (1996). https://doi.org/10.2165/00128413-199610200-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199610200-00013

Keywords

Search

Navigation